Page last updated: 2024-08-22

camptothecin and MPTP Neurotoxicity Syndrome

camptothecin has been researched along with MPTP Neurotoxicity Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biswas, SC; Greene, LA; Jackson-Lewis, V; Malagelada, C; Ryu, EJ1

Other Studies

1 other study(ies) available for camptothecin and MPTP Neurotoxicity Syndrome

ArticleYear
RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2006, Sep-27, Volume: 26, Issue:39

    Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Camptothecin; DNA-Binding Proteins; Gene Expression Regulation; Humans; Hydrogen Peroxide; Male; Melanins; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Growth Factor; Neurons; Oxidopamine; Parkinsonian Disorders; PC12 Cells; Phosphorylation; Protein Kinases; Protein Processing, Post-Translational; Rats; Repressor Proteins; Ribosomal Protein S6 Kinases, 70-kDa; RNA; RNA Interference; Rotenone; Signal Transduction; Substantia Nigra; TOR Serine-Threonine Kinases; Transcription Factors; Transcription, Genetic; Transfection; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins; Tunicamycin

2006